Richmond Hill, Canada

Mohammed N Kabir

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Apotex Technologies Inc.. Active years: 2014.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mohammed N Kabir: Innovator in Pharmaceutical Formulations

Introduction

Mohammed N Kabir is a notable inventor based in Richmond Hill, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral formulations that enhance patient compliance.

Latest Patents

One of his key patents is a liquid formulation for deferiprone with a palatable taste. This innovative oral pharmaceutical liquid formulation comprises deferiprone and a taste masking composition. The taste masking composition includes an effective amount of a sweetener, such as sucralose, a thickening and suspension aid like hydroxyethylcellulose, a humectant such as glycerin, and at least one flavoring agent. The final product is designed to have a substantially non-bitter and palatable taste, making it more acceptable for patients.

Career Highlights

Mohammed N Kabir is associated with Apotex Technologies Inc., a company known for its commitment to developing high-quality generic pharmaceuticals. His work has led to advancements in the formulation of medications, particularly those that require improved taste profiles for better patient adherence.

Collaborations

He has collaborated with colleagues such as Michael Spino and Anita Hui, contributing to a dynamic team focused on pharmaceutical innovation.

Conclusion

Mohammed N Kabir's work in developing palatable pharmaceutical formulations exemplifies the importance of innovation in medicine. His contributions are paving the way for more effective treatments that cater to patient needs.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…